Last 12 months
Inside the activity.
0 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 03, 2025 Filed Mar 5, 2025 21:47 UTC |
Ban RandySee Remarks
|
SaleCommon Stock | 2,236 | $185.37 | $414,484.86 |
DisclosureSEC source: 0001104659-25-020916 · tm258354-2_4seq1.xml · nonDerivative · entry 1 Ban Randy · CIK 0001737127 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,970 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $184.64 to $185.63. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 02:31 UTC |
Rondoni JohnChief Technology Officer
|
Tax withholdingCommon Stock | 1,009 | $186.45 | $188,128.05 |
DisclosureSEC source: 0001104659-25-017091 · tm257622-3_4seq1.xml · nonDerivative · entry 2 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,787 F2 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 02:31 UTC |
Rondoni JohnChief Technology Officer
|
GrantCommon Stock | 3,296 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-017091 · tm257622-3_4seq1.xml · nonDerivative · entry 1 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,796 F1 · shares: Reflects an award of shares of common stock following the vesting of previously granted performance stock units. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 02:32 UTC |
Herbert Timothy P.Director · CEO and President
|
Tax withholdingCommon Stock | 8,273 | $186.45 | $1,542,500.85 |
DisclosureSEC source: 0001104659-25-017093 · tm257622-5_4seq1.xml · nonDerivative · entry 2 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,149 F2 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 02:32 UTC |
Herbert Timothy P.Director · CEO and President
|
GrantCommon Stock | 18,458 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-017093 · tm257622-5_4seq1.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,422 F1 · shares: Reflects an award of shares of common stock following the vesting of previously granted performance stock units. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 02:31 UTC |
Phillips Bryan KSee Remarks
|
Tax withholdingCommon Stock | 2,206 | $186.45 | $411,308.70 |
DisclosureSEC source: 0001104659-25-017092 · tm257622-4_4seq1.xml · nonDerivative · entry 2 Phillips Bryan K · CIK 0001412895 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,236 F2 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 02:31 UTC |
Phillips Bryan KSee Remarks
|
GrantCommon Stock | 6,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-017092 · tm257622-4_4seq1.xml · nonDerivative · entry 1 Phillips Bryan K · CIK 0001412895 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,442 F1 · shares: Reflects an award of shares of common stock following the vesting of previously granted performance stock units. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 02:30 UTC |
Buchholz RichardChief Financial Officer
|
Tax withholdingCommon Stock | 2,200 | $186.45 | $410,190.00 |
DisclosureSEC source: 0001104659-25-017090 · tm257622-2_4seq1.xml · nonDerivative · entry 7 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,126 F2 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 02:30 UTC |
Buchholz RichardChief Financial Officer
|
GrantCommon Stock | 6,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-017090 · tm257622-2_4seq1.xml · nonDerivative · entry 6 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,326 F1 · shares: Reflects an award of shares of common stock following the vesting of previously granted performance stock units. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 02:30 UTC |
Ban RandySee Remarks
|
Tax withholdingCommon Stock | 2,205 | $186.45 | $411,122.25 |
DisclosureSEC source: 0001104659-25-017089 · tm257622-1_4seq1.xml · nonDerivative · entry 2 Ban Randy · CIK 0001737127 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,206 F2 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a performance stock unit award. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 02:30 UTC |
Ban RandySee Remarks
|
GrantCommon Stock | 6,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-017089 · tm257622-1_4seq1.xml · nonDerivative · entry 1 Ban Randy · CIK 0001737127 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,411 F1 · shares: Reflects an award of shares of common stock following the vesting of previously granted performance stock units. Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 02:30 UTC |
Buchholz RichardChief Financial Officer
|
GiftCommon Stock | 125 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-017090 · tm257622-2_4seq1.xml · nonDerivative · entry 5 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Held by son Disclosed balance after: 1,475 Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 02:30 UTC |
Buchholz RichardChief Financial Officer
|
GiftCommon Stock | 125 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-017090 · tm257622-2_4seq1.xml · nonDerivative · entry 4 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Held by son Disclosed balance after: 1,475 Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 02:30 UTC |
Buchholz RichardChief Financial Officer
|
GiftCommon Stock | 125 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-017090 · tm257622-2_4seq1.xml · nonDerivative · entry 3 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Held by son Disclosed balance after: 1,475 Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 02:30 UTC |
Buchholz RichardChief Financial Officer
|
GiftCommon Stock | 125 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-017090 · tm257622-2_4seq1.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Held by daughter Disclosed balance after: 1,475 Read SEC document |
| February 21, 2025 Filed Feb 26, 2025 02:30 UTC |
Buchholz RichardChief Financial Officer
|
GiftCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-017090 · tm257622-2_4seq1.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,174 Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 23:43 UTC |
Mann MelissaChief People Officer
|
GrantCommon Stock | 5,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-014858 · tm256927-3_4seq1.xml · nonDerivative · entry 1 Mann Melissa · CIK 0002031034 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,266 F1 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 13, 2026. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 23:42 UTC |
Rondoni JohnChief Technology Officer
|
GrantCommon Stock | 5,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-014857 · tm256927-2_4seq1.xml · nonDerivative · entry 1 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,500 F1 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 13, 2026. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 23:48 UTC |
Weatherby CarltonSee Remarks
|
GrantCommon Stock | 5,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-014870 · tm256927-7_4seq1.xml · nonDerivative · entry 2 Weatherby Carlton · CIK 0001986335 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,457 F1 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 13, 2026. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 23:46 UTC |
Buchholz RichardChief Financial Officer
|
GrantCommon Stock | 5,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-014866 · tm256927-6_4seq1.xml · nonDerivative · entry 2 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,674 F2 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 13, 2026. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 23:44 UTC |
Ban RandySee Remarks
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $67.63 | $0.00 |
DisclosureSEC source: 0001104659-25-014860 · tm256927-4_4seq1.xml · derivative · entry 16 Ban Randy · CIK 0001737127 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2029-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F14 · derivative.exercise_date: Fully vested and exercisable. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 23:44 UTC |
Ban RandySee Remarks
|
SaleCommon Stock | 584 | $187.66 | $109,593.44 |
DisclosureSEC source: 0001104659-25-014860 · tm256927-4_4seq1.xml · nonDerivative · entry 13 Ban Randy · CIK 0001737127 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,259 F4 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 13, 2024 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 23:44 UTC |
Ban RandySee Remarks
|
SaleCommon Stock | 3,341 | $186.96 | $624,648.39 |
DisclosureSEC source: 0001104659-25-014860 · tm256927-4_4seq1.xml · nonDerivative · entry 12 Ban Randy · CIK 0001737127 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,843 F4 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 13, 2024 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.35 to $187.29. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 23:44 UTC |
Ban RandySee Remarks
|
SaleCommon Stock | 3,824 | $185.84 | $710,646.42 |
DisclosureSEC source: 0001104659-25-014860 · tm256927-4_4seq1.xml · nonDerivative · entry 11 Ban Randy · CIK 0001737127 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,184 F4 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 13, 2024 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.35 to $186.32. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 23:44 UTC |
Ban RandySee Remarks
|
SaleCommon Stock | 3,452 | $184.81 | $637,965.16 |
DisclosureSEC source: 0001104659-25-014860 · tm256927-4_4seq1.xml · nonDerivative · entry 10 Ban Randy · CIK 0001737127 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,008 F4 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 13, 2024 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $184.33 to $185.31. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 23:44 UTC |
Ban RandySee Remarks
|
SaleCommon Stock | 2,541 | $183.79 | $467,015.73 |
DisclosureSEC source: 0001104659-25-014860 · tm256927-4_4seq1.xml · nonDerivative · entry 9 Ban Randy · CIK 0001737127 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,460 F4 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 13, 2024 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $183.31 to $184.30. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 23:44 UTC |
Ban RandySee Remarks
|
SaleCommon Stock | 3,242 | $182.90 | $592,946.56 |
DisclosureSEC source: 0001104659-25-014860 · tm256927-4_4seq1.xml · nonDerivative · entry 8 Ban Randy · CIK 0001737127 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,001 F4 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 13, 2024 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.30 to $183.27. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 23:44 UTC |
Ban RandySee Remarks
|
SaleCommon Stock | 3,770 | $181.90 | $685,756.97 |
DisclosureSEC source: 0001104659-25-014860 · tm256927-4_4seq1.xml · nonDerivative · entry 7 Ban Randy · CIK 0001737127 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,243 F4 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 13, 2024 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $181.30 to $182.26. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 23:44 UTC |
Ban RandySee Remarks
|
SaleCommon Stock | 1,330 | $180.79 | $240,446.71 |
DisclosureSEC source: 0001104659-25-014860 · tm256927-4_4seq1.xml · nonDerivative · entry 6 Ban Randy · CIK 0001737127 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,013 F4 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 13, 2024 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $180.29 to $181.27. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 23:44 UTC |
Ban RandySee Remarks
|
SaleCommon Stock | 1,000 | $179.41 | $179,406.70 |
DisclosureSEC source: 0001104659-25-014860 · tm256927-4_4seq1.xml · nonDerivative · entry 5 Ban Randy · CIK 0001737127 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,343 F4 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 13, 2024 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $179.12 to $179.75. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 23:44 UTC |
Ban RandySee Remarks
|
SaleCommon Stock | 2,500 | $178.54 | $446,339.50 |
DisclosureSEC source: 0001104659-25-014860 · tm256927-4_4seq1.xml · nonDerivative · entry 4 Ban Randy · CIK 0001737127 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,343 F4 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 13, 2024 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.08 to $178.93. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 23:44 UTC |
Ban RandySee Remarks
|
Exercise / conversionCommon Stock | 25,000 | $67.63 | $1,690,750.00 |
DisclosureSEC source: 0001104659-25-014860 · tm256927-4_4seq1.xml · nonDerivative · entry 3 Ban Randy · CIK 0001737127 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 32,843 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 23:44 UTC |
Ban RandySee Remarks
|
GrantCommon Stock | 5,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-014860 · tm256927-4_4seq1.xml · nonDerivative · entry 2 Ban Randy · CIK 0001737127 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,843 F3 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 13, 2026. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 23:45 UTC |
Phillips Bryan KSee Remarks
|
GrantCommon Stock | 5,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-014863 · tm256927-5_4seq1.xml · nonDerivative · entry 3 Phillips Bryan K · CIK 0001412895 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,290 F2 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 13, 2026. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 23:41 UTC |
Herbert Timothy P.Director · CEO and President
|
GrantCommon Stock | 16,029 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-014855 · tm256927-1_4seq1.xml · nonDerivative · entry 2 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,964 F2 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 13, 2026. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| February 13, 2025 Filed Feb 25, 2025 01:03 UTC |
Kelly Jason PSee Remarks
|
GrantCommon Stock | 4,541 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-016633 · tm257494-2_4seq1.xml · nonDerivative · entry 1 Kelly Jason P · CIK 0002057473 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,541 F1 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 13, 2026. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| February 11, 2025 Filed Feb 14, 2025 01:14 UTC |
Rondoni JohnChief Technology Officer
|
SaleCommon Stock | 583 | $170.49 | $99,395.67 |
DisclosureSEC source: 0001104659-25-013139 · tm256634-1_4seq1.xml · nonDerivative · entry 2 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,424 Read SEC document |
| February 09, 2025 Filed Feb 14, 2025 01:14 UTC |
Rondoni JohnChief Technology Officer
|
Tax withholdingCommon Stock | 315 | $182.15 | $57,377.25 |
DisclosureSEC source: 0001104659-25-013139 · tm256634-1_4seq1.xml · nonDerivative · entry 1 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,007 Read SEC document |
| February 09, 2025 Filed Feb 18, 2025 23:48 UTC |
Weatherby CarltonSee Remarks
|
Tax withholdingCommon Stock | 313 | $182.15 | $57,012.95 |
DisclosureSEC source: 0001104659-25-014870 · tm256927-7_4seq1.xml · nonDerivative · entry 1 Weatherby Carlton · CIK 0001986335 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,381 Read SEC document |
| February 09, 2025 Filed Feb 18, 2025 23:46 UTC |
Buchholz RichardChief Financial Officer
|
Tax withholdingCommon Stock | 314 | $182.15 | $57,195.10 |
DisclosureSEC source: 0001104659-25-014866 · tm256927-6_4seq1.xml · nonDerivative · entry 1 Buchholz Richard · CIK 0001737133 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,598 F1 · balance_after: Includes (i) 109 shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2024 and (ii) 32 shares acquired under the Plan on December 31, 2024. Read SEC document |
| February 09, 2025 Filed Feb 18, 2025 23:44 UTC |
Ban RandySee Remarks
|
Tax withholdingCommon Stock | 314 | $182.15 | $57,195.10 |
DisclosureSEC source: 0001104659-25-014860 · tm256927-4_4seq1.xml · nonDerivative · entry 1 Ban Randy · CIK 0001737127 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,767 F1 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award. F2 · balance_after: Includes 25 shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan on December 31, 2024. Read SEC document |
| February 09, 2025 Filed Feb 18, 2025 23:45 UTC |
Phillips Bryan KSee Remarks
|
Tax withholdingCommon Stock | 282 | $182.15 | $51,366.30 |
DisclosureSEC source: 0001104659-25-014863 · tm256927-5_4seq1.xml · nonDerivative · entry 2 Phillips Bryan K · CIK 0001412895 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,214 Read SEC document |
| February 09, 2025 Filed Feb 18, 2025 23:41 UTC |
Herbert Timothy P.Director · CEO and President
|
Tax withholdingCommon Stock | 896 | $182.15 | $163,206.40 |
DisclosureSEC source: 0001104659-25-014855 · tm256927-1_4seq1.xml · nonDerivative · entry 1 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,935 F1 · balance_after: Includes (i) 109 shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2024 and (ii) 32 shares acquired under the Plan on December 31, 2024. Read SEC document |
| January 29, 2025 Filed Feb 18, 2025 23:45 UTC |
Phillips Bryan KSee Remarks
|
Tax withholdingCommon Stock | 204 | $189.99 | $38,757.96 |
DisclosureSEC source: 0001104659-25-014863 · tm256927-5_4seq1.xml · nonDerivative · entry 1 Phillips Bryan K · CIK 0001412895 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,496 F1 · balance_after: Includes (i) 66 shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan (the "Plan") on June 30, 2024 and (ii) 63 shares acquired under the Plan on December 31, 2024. Read SEC document |
| January 15, 2025 Filed Jan 18, 2025 01:16 UTC |
Melenikiotou GeorgiaDirector
|
GrantCommon Stock | 80 | $176.33 | $14,106.40 |
DisclosureSEC source: 0001104659-25-004601 · tm253739-3_4seq1.xml · nonDerivative · entry 1 Melenikiotou Georgia · CIK 0001817552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,293 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| January 15, 2025 Filed Jan 18, 2025 02:19 UTC |
Ellis Gary LeeDirector
|
GrantCommon Stock | 137 | $176.33 | $24,157.21 |
DisclosureSEC source: 0001104659-25-004609 · tm253739-2_4seq1.xml · nonDerivative · entry 1 Ellis Gary Lee · CIK 0001290170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,426 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| January 15, 2025 Filed Jan 18, 2025 01:17 UTC |
Broader Shelley GDirector
|
GrantCommon Stock | 92 | $176.33 | $16,222.36 |
DisclosureSEC source: 0001104659-25-004602 · tm253739-4_4seq1.xml · nonDerivative · entry 1 Broader Shelley G. · CIK 0001426843 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,592 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| January 15, 2025 Filed Jan 18, 2025 01:15 UTC |
Tansey Casey MDirector
|
GrantCommon Stock | 81 | $176.33 | $14,282.73 |
DisclosureSEC source: 0001104659-25-004600 · tm253739-1_4seq1.xml · nonDerivative · entry 1 Tansey Casey M · CIK 0001474322 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,512 F1 · shares: Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:05 UTC |
Rondoni JohnChief Technology Officer
|
SaleCommon Stock | 58 | $215.00 | $12,470.00 |
DisclosureSEC source: 0001104659-25-002532 · tm252955-1_4seq1.xml · nonDerivative · entry 1 Rondoni John · CIK 0001932219 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,322 F1 · balance_after: Includes 32 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan since the Reporting Person's Form 4 dated November 5, 2024. Read SEC document |
| December 20, 2024 Filed Dec 23, 2024 21:15 UTC |
Herbert Timothy P.Director · CEO and President
|
OtherStock Option (Right to Buy) · Derivative | 2,915 | Not disclosed Strike: $227.53 | Not disclosed |
DisclosureSEC source: 0001104659-24-131302 · tm2431875-1_4seq1.xml · derivative · entry 9 Herbert Timothy P. · CIK 0001737136 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · By LLC Disclosed balance after: 5,553 Underlying: Common Stock · 2,915 shares Expires 2030-12-14 F1 · kind: Reflects the transfer of 52.5% of the membership units of TPH 2022 LLC by the Reporting Person and his spouse in connection with estate planning transactions. F1 · price: Reflects the transfer of 52.5% of the membership units of TPH 2022 LLC by the Reporting Person and his spouse in connection with estate planning transactions. F5 · derivative.exercise_date: The original grant of options to purchase 17,773 shares of common stock vested and became exercisable as to 25% of the underlying shares on the first anniversary of February 11, 2022 and the remaining 75% of the underlying shares have vested or will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F1 · balance_after: Reflects the transfer of 52.5% of the membership units of TPH 2022 LLC by the Reporting Person and his spouse in connection with estate planning transactions. F2 · ownership.nature: Securities held by TPH 2022 LLC. Subsequent to the transactions reported herein, the Reporting Person is no longer considered the beneficial owner of securities held by TPH 2022 LLC and will no longer report securities held by TPH 2022 LLC on its subsequent reports. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.